"EFFECTS OF KINESIO-TAPING ON PAIN, POSTURAL STABILITY AND FUNCTION IN PERSONS WITH DISCOGENIC LOW BACK PAIN"

NCT ID: NCT05713812

Last Updated: 2023-02-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-02-15

Study Completion Date

2023-08-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Low back pain is the leading cause of disability worldwide, the prevalence of low back pain can be as high as 43%. Past research has shown the positive effects of Kinesio taping in patients with chronic and nonspecific low back pain in pain reduction, improvement in postural stability, and improvement in function. However, no study has yet evaluated the effects of KT in persons with discogenic LBP. If found to be effective KT can be prescribed as a conservative \& cost-effective treatment for patients with discogenic low back pain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain Low Back Pain, Mechanical

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active Comparator

* IFC + Hot pack for 20 minutes
* MDT (prone positioning) for 10 minutes.
* Lumbar SNAGs + lumbar rotation mobilization.
* Home exercise plan: MDT for 10 min + patient education to avoid flexion based activities.
* Sham Kinesiotape will be applied

Group Type ACTIVE_COMPARATOR

Control Treatment

Intervention Type PROCEDURE

IFC + Hot pack for 20 minutes MDT (prone positioning) for 10 minutes. Lumbar SNAGs + lumbar rotation mobilization. Home exercise plan: MDT for 10 min + patient education to avoid flexion based activities.

Experimental Group

* IFC + Hot pack for 20 minutes
* MDT (Prone positioning) for 10 minutes.
* Lumbar SNAGs + lumbar rotation mobilization.
* Home exercise plan: MDT for 10 min + patient education to avoid flexion based activities.
* Kinesiotape will be applied

Group Type EXPERIMENTAL

Kinesiotaping

Intervention Type PROCEDURE

Kinesiotape will be applied

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kinesiotaping

Kinesiotape will be applied

Intervention Type PROCEDURE

Control Treatment

IFC + Hot pack for 20 minutes MDT (prone positioning) for 10 minutes. Lumbar SNAGs + lumbar rotation mobilization. Home exercise plan: MDT for 10 min + patient education to avoid flexion based activities.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age20-45 years.
* Positive straight leg raise (SLR)
* Posterolateral disc bulge, herniation or prolapse indicated by MRI.
* Positive centralization and peripheralization phenomenon.

Exclusion Criteria

* Participants having spondylolisthesis, fractures, tumors, osteoporosis, infection, or spinal stenosis.
* History of lumbar spine surgery and patients that are already receiving any physical therapy or exercise
* Skin allergy or sensitivity to the tape.
* Neurological, rheumatologic, or psychiatric disease
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Foundation University Islamabad

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sameen Tariq, DPT

Role: PRINCIPAL_INVESTIGATOR

Foundation University Islamabad

Muhammad Osama, PhD*

Role: STUDY_DIRECTOR

Foundation University Islamabad

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Foundation University Islamabad

Islamabad, Federal, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FUI/CTR/2023/4

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.